Aleks Radovic-Moreno, PhD, is on the leadership team of Alivio and is a Vice President at PureTech Health, the parent company of Alivio. He was previously a Research Scientist at the biotech startup, AuraSense Therapeutics (Exicure Inc), where he was a lead inventor of the company’s core immunotherapy platform. Dr. Radovic-Moreno completed his graduate work as a NSF Fellow in Robert Langer’s lab at MIT, where he developed novel strategies for managing bacterial infections, including a novel vaccine candidate for chlamydia, a disease for which no vaccine currently exists. Dr. Radovic-Moreno was awarded the Alumni Achievement Award by the Pennsylvania State University for extraordinary professional accomplishment by graduates under the age of 35. He received his B.S. in Chemical Engineering from the Pennsylvania State University and PhD in Chemical and Biomedical Engineering from MIT and the Harvard-MIT Division of Health Sciences & Technology.
Aleks Radovic-Moreno
